These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21715597)

  • 1. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
    Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
    Fischer K; Nguyen K; LiWang PJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
    Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.
    Alexandre KB; Gray ES; Lambson BE; Moore PL; Choge IA; Mlisana K; Karim SS; McMahon J; O'Keefe B; Chikwamba R; Morris L
    Virology; 2010 Jun; 402(1):187-96. PubMed ID: 20392471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of transmitted and founder human immunodeficiency virus type 1 envelopes to carbohydrate-binding agents griffithsin, cyanovirin-N and Galanthus nivalis agglutinin.
    Hu B; Du T; Li C; Luo S; Liu Y; Huang X; Hu Q
    J Gen Virol; 2015 Dec; 96(12):3660-3666. PubMed ID: 26407826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
    Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.
    Hu Q; Mahmood N; Shattock RJ
    Virology; 2007 Nov; 368(1):145-54. PubMed ID: 17658575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.
    Alexandre KB; Moore PL; Nonyane M; Gray ES; Ranchobe N; Chakauya E; McMahon JB; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2013 Nov; 446(1-2):66-76. PubMed ID: 24074568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.
    Banerjee K; Michael E; Eggink D; van Montfort T; Lasnik AB; Palmer KE; Sanders RW; Moore JP; Klasse PJ
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):206-14. PubMed ID: 21793733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
    Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
    Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity.
    Hoorelbeke B; Van Damme EJ; Rougé P; Schols D; Van Laethem K; Fouquaert E; Balzarini J
    Retrovirology; 2011 Feb; 8(1):10. PubMed ID: 21314946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains.
    Férir G; Huskens D; Palmer KE; Boudreaux DM; Swanson MD; Markovitz DM; Balzarini J; Schols D
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1513-23. PubMed ID: 22607556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis.
    Balzarini J; Van Laethem K; Hatse S; Froeyen M; Van Damme E; Bolmstedt A; Peumans W; De Clercq E; Schols D
    Mol Pharmacol; 2005 May; 67(5):1556-65. PubMed ID: 15718224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.
    Balzarini J; Van Laethem K; Peumans WJ; Van Damme EJ; Bolmstedt A; Gago F; Schols D
    J Virol; 2006 Sep; 80(17):8411-21. PubMed ID: 16912292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
    Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
    J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
    Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
    J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.